- Home
- RNAC vs SOPH Comparison
RNAC vs SOPH Comparison
Compare RNAC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- SOPH
- Stock Information
- Founded
- RNAC 2007
- SOPH 2011
- Country
- RNAC United States
- SOPH Switzerland
- Employees
- RNAC N/A
- SOPH N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RNAC Health Care
- SOPH Health Care
- Exchange
- RNAC Nasdaq
- SOPH Nasdaq
- Market Cap
- RNAC 276.3M
- SOPH 231.8M
- IPO Year
- RNAC 2016
- SOPH 2021
- Fundamental
- Price
- RNAC $9.67
- SOPH $4.18
- Analyst Decision
- RNAC Strong Buy
- SOPH
- Analyst Count
- RNAC 4
- SOPH 0
- Target Price
- RNAC $40.00
- SOPH N/A
- AVG Volume (30 Days)
- RNAC 83.4K
- SOPH 92.3K
- Earning Date
- RNAC 11-06-2025
- SOPH 11-04-2025
- Dividend Yield
- RNAC N/A
- SOPH N/A
- EPS Growth
- RNAC N/A
- SOPH N/A
- EPS
- RNAC N/A
- SOPH N/A
- Revenue
- RNAC $1,026,000.00
- SOPH $69,688,000.00
- Revenue This Year
- RNAC N/A
- SOPH $16.60
- Revenue Next Year
- RNAC N/A
- SOPH $18.77
- P/E Ratio
- RNAC N/A
- SOPH N/A
- Revenue Growth
- RNAC N/A
- SOPH 7.32
- 52 Week Low
- RNAC $8.46
- SOPH $2.58
- 52 Week High
- RNAC $26.50
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- RNAC 44.74
- SOPH 57.45
- Support Level
- RNAC $9.87
- SOPH $3.91
- Resistance Level
- RNAC $10.48
- SOPH $4.90
- Average True Range (ATR)
- RNAC 0.62
- SOPH 0.39
- MACD
- RNAC 0.07
- SOPH 0.04
- Stochastic Oscillator
- RNAC 41.25
- SOPH 60.12
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.